Wordt geladen...
Rivastigmine for Alzheimer's disease
BACKGROUND: Alzheimer's disease is the commonest cause of dementia affecting older people. One of the therapeutic strategies aimed at ameliorating the clinical manifestations of Alzheimer's disease is to enhance cholinergic neurotransmission in the brain by the use of cholinesterase inhibi...
Bewaard in:
| Gepubliceerd in: | Cochrane Database Syst Rev |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Ltd
2015
|
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7050299/ https://ncbi.nlm.nih.gov/pubmed/26393402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001191.pub4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|